Ib-II gastric cancer

Clinical trials for Ib-II gastric cancer explained in plain language.

Never miss a new study

Get alerted when new Ib-II gastric cancer trials appear

Sign up with your email to follow new studies for Ib-II gastric cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can an antibody boost chemotherapy to stop early stomach cancer from returning?

Disease control Recruiting now

This trial is testing whether adding the targeted antibody trastuzumab to standard chemotherapy after surgery can help prevent early-stage (IB-II) HER2-positive gastric cancer from coming back. About 120 adults who have had their tumor removed will be randomly assigned to receive…

Matched conditions: IB-II GASTRIC CANCER

Phase 2 • Sponsor: Xijing Hospital • Aim: Disease control

Last updated Aug 28, 2026 00:00 UTC

Ib-II gastric cancer

Get alerted when new Ib-II gastric cancer trials appear

Can an antibody boost chemotherapy to stop early stomach cancer from returning?